Main Article Content
This work is licensed under a Creative Commons Attribution 4.0 International License.
Our edition uses the copyright terms of Creative Commons for open access journals.
Authors, who are published in this journal, agree with the following terms:
- The authors retain rights for authorship of their article and grant to the edition the right of first publication of the article on a Creative Commons Attribution 4.0 International License, which allows others to freely distribute the published article, with the obligatory reference to the authors of original works and original publication in this journal.
- Directing the article for the publication to the editorial board (publisher), the author agrees with transmitting of rights for the protection and using the article, including parts of the article, which are protected by the copyrights, such as the author’s photo, pictures, charts, tables, etc., including the reproduction in the media and the Internet; for distributing; for the translation of the manuscript in all languages; for export and import of the publications copies of the writers’ article to spread, bringing to the general information.
- The rights mentioned above authors transfer to the edition (publisher) for the unlimited period of validity and on the territory of all countries of the world.
- The authors guarantee that they have exclusive rights for using of the article, which they have sent to the edition (publisher). The edition (the publisher) is not responsible for the violation of given guarantees by the authors to the third parties.
- The authors have the right to conclude separate supplement agreements that relate to non-exclusive distribution of their article in the form in which it had been published in the journal (for example, to upload the work to the online storage of the journal or publish it as part of a monograph), provided that the reference to the first publication of the work in this journal is included.
- The policy of the journal permits and encourages the publication of the article in the Internet (in institutional repository or on a personal website) by the authors, because it contributes to productive scientific discussion and a positive effect on efficiency and dynamics of the citation of the article.
Urmanova YuM, Alimova KB. Giant pituitary adenomas: prevalence, features of diagnosis clinical course Mìžnarodnij endokrinologìčnij žurnal. 2018;14(5):539-542. doi: 10.22141/2224-0722.214.171.1248.143018. (in Russian).
Chohan MO, Levin AM, Singh R, et al. Three-dimensional volumetric measurements in defining endoscope-guided giant adenoma surgery outcomes. Pituitary. 2016;19(3):311-321. doi:10.1007/s11102-016-0709-2.
Raverot G, Jouanneau E, Trouillas J. Management of endocrine disease: clinicopathological classification and molecular markers of pituitary tumours for personalized therapeutic strategies. Eur J Endocrinol. 2014;170(4):R121-R132. Published 2014 Mar 13. doi:10.1530/EJE-13-1031.
Coli A, Asa SL, Fadda G, et al. Minichromosome maintenance protein 7 as prognostic marker of tumor aggressiveness in pituitary adenoma patients. Eur J Endocrinol. 2016;174(3):307-314. doi:10.1530/EJE-15-0586.
Zhenye L, Chuzhong L, Youtu W, et al. The expression of TGF-β1, Smad3, phospho-Smad3 and Smad7 is correlated with the development and invasion of nonfunctioning pituitary adenomas. J Transl Med. 2014;12:71. doi:10.1186/1479-5876-12-71.
Das B, Batool S, Khoja A, Islam N. Presentation, Management, and Outcomes of Nonfunctioning Pituitary Adenomas: An Experience from a Developing Country. Cureus. 2019;11(9):e5759. doi:10.7759/cureus.5759.
Kim YH, Kim JH. Transcriptome Analysis Identifies an Attenuated Local Immune Response in Invasive Nonfunctioning Pituitary Adenomas. Endocrinol Metab (Seoul). 2019;34(3):314-322. doi:10.3803/EnM.2019.34.3.314.
Zakir JC, Casulari LA, Rosa JW, et al. Prognostic Value of Invasion, Markers of Proliferation, and Classification of Giant Pituitary Tumors, in a Georeferred Cohort in Brazil of 50 Patients, with a Long-Term Postoperative Follow-Up. Int J Endocrinol. 2016;2016:7964523. doi:10.1155/2016/7964523.
Landeiro JA, Fonseca EO, Monnerat AL, Taboada GF, Cabral GA, Antunes F. Nonfunctioning giant pituitary adenomas: Invasiveness and recurrence. Surg Neurol Int. 2015;6:179. doi:10.4103/2152-7806.170536.
Mercado M, Melgar V, Salame L, Cuenca D. Clinically non-functioning pituitary adenomas: Pathogenic, diagnostic and therapeutic aspects. Endocrinol Diabetes Nutr. 2017;64(7):384-395. doi:10.1016/j.endinu.2017.05.009.
Nishioka H, Hara T, Nagata Y, Fukuhara N, Yamaguchi-Okada M, Yamada S. Inherent Tumor Characteristics That Limit Effective and Safe Resection of Giant Nonfunctioning Pituitary Adenomas. World Neurosurg. 2017;106:645-652. doi:10.1016/j.wneu.2017.07.043.
Kalensky O, Kalensky L, Bilohash S, Garden O. Prognostic significance of Ki-67 expression in pituitary adenomas. Actual issues of clinical and preventive medicine. 2015;3(3-4):33-37 (in Ukrainian).